Bausch Health Companies Inc.(BHC)Earnings, Financials & Key Ratios

BHC•NYSE

$5.64

$2.11B mkt cap·13.1× P/E·Price updated May 6, 2026

SectorHealthcare IndustrySpecialty & Generic Pharma Sub-IndustrySpecialty pharma brand consolidators

AboutBausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.Show more

Revenue$10.45B+8.5%
EBITDA$3.45B+22.7%
Net Income$160M+447.3%
EPS (Diluted)0.43+430.8%
Gross Margin60.9%-14.3%
EBITDA Margin33.05%+13.1%
Operating Margin21.28%+32.5%
Net Margin1.53%+420.0%
ROE588.24%
ROIC8.22%+47.7%
Debt/Equity56.36
Interest Coverage1.35+0.6%

Technical→

BHC Key Insights

Bausch Health Companies Inc. (BHC) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income

✗Weaknesses

✗High debt to equity ratio of 56.4x
✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

BHC Price & Volume

Bausch Health Companies Inc. (BHC) stock price & volume — 10-year historical chart

Loading chart...

BHC Growth Metrics

Bausch Health Companies Inc. (BHC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years0%

5 Years5.41%

3 Years8.74%

TTM8.52%

Profit CAGR

10 Years-

5 Years-

3 Years-

TTM-2886.81%

EPS CAGR

10 Years-

5 Years-

3 Years-

TTM-2758.41%

Return on Capital

10 Years1.82%

5 Years5.18%

3 Years7.38%

Last Year10.61%

BHC Recent Earnings

Bausch Health Companies Inc. (BHC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 6/12 qtrs (50%)●Beat Revenue 7/12 qtrs (58%)

Q2 2026Latest

Apr 29, 2026

EPS

$0.78

Est $0.81

-3.7%

Revenue

$2.5B

Est $2.4B

+4.3%

Q1 2026

Feb 18, 2026

EPS

$1.08

Est $1.21

-10.7%

Revenue

$2.8B

Est $2.7B

+2.1%

Q4 2025

Oct 29, 2025

EPS

$1.16

Est $1.07

+8.4%

Revenue

$2.7B

Est $2.7B

-1.0%

Q3 2025

Jul 30, 2025

EPS

$0.90

Est $0.97

-7.2%

Revenue

$2.5B

Est $2.6B

-2.1%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	Apr 29, 2026	$0.78vs $0.81-3.7%	$2.5Bvs $2.4B+4.3%
Q1 2026	Feb 18, 2026	$1.08vs $1.21-10.7%	$2.8Bvs $2.7B+2.1%
Q4 2025	Oct 29, 2025	$1.16vs $1.07+8.4%	$2.7Bvs $2.7B-1.0%
Q3 2025	Jul 30, 2025	$0.90vs $0.97-7.2%	$2.5Bvs $2.6B-2.1%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	FCF Yield	Debt / Equity
PBHPrestige Consumer Healthcare Inc.Direct Competitor	2.64B	55.75	13.00	1.1%	16.9%	10.19%	9.22%	0.57
PRGOPerrigo Company plcDirect Competitor	1.6B	11.64	-1.13	-2.75%	-33.51%	-48.56%	9.06%	0.01
BLCOBausch + Lomb CorporationProduct Competitor	5.7B	16.00	-15.69	6.47%	-4.21%	-3.37%		0.82
COOThe Cooper Companies, Inc.Product Competitor	12B	61.25	32.75	5.06%	9.67%	4.83%	3.61%	0.34
ABTAbbott LaboratoriesProduct Competitor	151.59B	87.18	11.41	4.59%	31.88%	27.26%	4.19%	0.32
ALCOAlico, Inc.Product Competitor	316.07M	41.28	-2.14	-5.52%	-487.45%	-135.59%	4.63%	0.79
NVSNovartis AGProduct Competitor	277.63B	145.50	20.24	5.97%	24.14%	31.42%	6.37%	0.80
EWEdwards Lifesciences CorporationProduct Competitor	47.8B	82.91	45.31	11.55%	17.64%	10.35%	2.79%	0.07

Compare BHC vs Peers

Bausch Health Companies Inc. (BHC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs PBH

Most directly comparable listed peer for BHC.

Scale Benchmark

vs NVS

Larger-name benchmark to compare BHC against a more recognizable public peer.

Peer Set

Compare Top 5

vs PBH, PRGO, BLCO, COO

BHC Income Statement

Bausch Health Companies Inc. (BHC) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	8.72B	8.38B	8.6B	8.03B	8.43B	8.12B	8.76B	9.63B	10.45B	10.55B
Revenue Growth %	-9.82%	-3.94%	2.64%	-6.67%	5.07%	-3.68%	7.79%	9.91%	8.53%	8.52%
Cost of Goods Sold	2.55B	2.35B	2.35B	2.25B	2.39B	2.36B	2.56B	2.78B	4.08B	4.04B
COGS % of Revenue	29.21%	28.05%	27.32%	28.02%	28.39%	29.1%	29.22%	28.9%	39.1%	-
Gross Profit	6.18B▲ 0%	6.03B▼ 2.4%	6.25B▲ 3.7%	5.78B▼ 7.6%	6.04B▲ 4.5%	5.76B▼ 4.6%	6.2B▲ 7.6%	6.84B▲ 10.4%	6.36B▼ 7.0%	6.51B▲ 0%
Gross Margin %	70.79%	71.95%	72.68%	71.98%	71.61%	70.9%	70.78%	71.1%	60.9%	61.67%
Gross Profit Growth %	-13.03%	-2.38%	3.68%	-7.57%	4.53%	-4.64%	7.6%	10.41%	-7.04%	-
Operating Expenses	6.07B	8.41B	6.45B	5.1B	5.59B	5.31B	5.24B	5.3B	4.14B	4.09B
OpEx % of Revenue	69.62%	100.39%	75.04%	63.56%	66.28%	65.31%	59.78%	55.03%	39.62%	-
Selling, General & Admin	2.58B	2.47B	2.55B	2.37B	2.49B	2.53B	2.9B	3.28B	3.5B	3.44B
SG&A % of Revenue	29.6%	29.51%	29.69%	29.49%	29.55%	31.15%	33.06%	34.11%	33.49%	-
Research & Development	369M	442M	516M	485M	473M	530M	604M	634M	640.01M	650.07M
R&D % of Revenue	4.23%	5.27%	6%	6.04%	5.61%	6.52%	6.9%	6.59%	6.13%	-
Other Operating Expenses	3.12B	5.5B	3.38B	2.25B	2.63B	2.25B	1.74B	1.38B	1	3
Operating Income	102M▲ 0%	-2.38B▼ 2437.3%	-203M▲ 91.5%	676M▲ 433.0%	450M▼ 33.4%	454M▲ 0.9%	963M▲ 112.1%	1.55B▲ 60.5%	2.22B▲ 43.8%	2.42B▲ 0%
Operating Margin %	1.17%	-28.45%	-2.36%	8.42%	5.34%	5.59%	11%	16.06%	21.28%	22.91%
Operating Income Growth %	118.02%	-2437.25%	91.48%	433%	-33.43%	0.89%	112.11%	60.54%	43.81%	-
EBITDA	2.96B	435M	1.87B	2.5B	2B	1.85B	2.23B	2.81B	3.45B	3.62B
EBITDA Margin %	33.93%	5.19%	21.76%	31.16%	23.74%	22.75%	25.43%	29.23%	33.05%	34.28%
EBITDA Growth %	28.7%	-85.3%	330.34%	33.6%	-19.95%	-7.69%	20.51%	26.31%	22.73%	28.88%
D&A (Non-Cash Add-back)	2.86B	2.82B	2.08B	1.82B	1.55B	1.39B	1.26B	1.27B	1.23B	1.2B
EBIT	555M	500M	1.34B	1.31B	1.71B	1.48B	1.62B	1.87B	2.22B	2.42B
Net Interest Income	-1.83B	-1.67B	-1.6B	-1.52B	-1.42B	-1.45B	-1.3B	-1.35B	-1.59B	-1.64B
Interest Income	12M	11M	12M	13M	7M	14M	26M	33M	48.84M	47.05M
Interest Expense	1.84B	1.69B	1.61B	1.53B	1.43B	1.46B	1.33B	1.39B	1.64B	1.69B
Other Income/Expense	-1.84B	-1.77B	-1.63B	-1.61B	-1.47B	-583M	-1.35B	-1.38B	-1.85B	-3.34B
Pretax Income	-1.74B▲ 0%	-4.15B▼ 138.6%	-1.84B▲ 55.8%	-934M▲ 49.2%	-1.02B▼ 9.6%	-129M▲ 87.4%	-390M▼ 202.3%	167M▲ 142.8%	373.42M▲ 123.6%	-920.44M▲ 0%
Pretax Margin %	-19.96%	-49.57%	-21.36%	-11.64%	-12.14%	-1.59%	-4.45%	1.74%	3.57%	-8.72%
Income Tax	-4.14B	-10M	-54M	-375M	-87M	83M	221M	239M	251.32M	286.17M
Effective Tax Rate %	238.08%	0.24%	2.94%	40.15%	8.5%	-64.34%	-56.67%	143.11%	67.3%	-31.09%
Net Income	2.4B▲ 0%	-4.15B▼ 272.5%	-1.78B▲ 57.0%	-559M▲ 68.6%	-948M▼ 69.6%	-225M▲ 76.3%	-592M▼ 163.1%	-46M▲ 92.2%	159.75M▲ 447.3%	-1.19B▲ 0%
Net Margin %	27.56%	-49.5%	-20.73%	-6.96%	-11.24%	-2.77%	-6.76%	-0.48%	1.53%	-11.27%
Net Income Growth %	199.79%	-272.55%	57.02%	68.65%	-69.59%	76.27%	-163.11%	92.23%	447.28%	-2886.81%
Net Income (Continuing)	2.4B	-4.14B	-1.78B	-559M	-937M	-212M	-611M	-72M	122.1M	-1.21B
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	95M	82M	73M	70M	72M	952M	940M	957M	929.31M	977M
EPS (Diluted)	8.59▲ 0%	-11.86▼ 238.1%	-5.06▲ 57.3%	-1.57▲ 69.0%	-2.61▼ 66.2%	-0.62▲ 76.2%	-1.62▼ 161.3%	-0.13▲ 92.0%	0.43▲ 430.8%	-3.19▲ 0%
EPS Growth %	223.78%	-238.07%	57.34%	68.97%	-66.24%	76.25%	-161.29%	91.98%	430.77%	-2758.41%
EPS (Basic)	8.63	-11.86	-5.06	-1.57	-2.61	-0.62	-1.62	-0.13	0.43	-
Diluted Shares Outstanding	351.8M	349.87M	352.1M	355M	358.9M	362M	364.9M	368M	375M	372.8M
Basic Shares Outstanding	350.2M	349.87M	352.1M	355M	358.9M	362M	365.43M	368M	370.9M	372.8M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

BHC Balance Sheet

Bausch Health Companies Inc. (BHC) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	4.75B	723M	6.97B	5.34B	5.61B	4.25B	5.6B	5.77B	6.15B	5.98B
Cash & Short-Term Investments	720M	721M	3.24B	605M	582M	564M	947M	1.18B	1.32B	1.3B
Cash Only	720M	721M	3.24B	605M	582M	564M	947M	1.18B	1.32B	1.3B
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	2.13B	1.86B	1.84B	1.58B	1.77B	1.79B	2B	2.14B	2.35B	2.19B
Days Sales Outstanding	89.12	81.23	78.04	71.71	76.82	80.42	83.28	81.15	82	79.23
Inventory	1.05B	934M	1.11B	1.09B	993M	1.09B	1.54B	1.59B	1.63B	1.6B
Days Inventory Outstanding	150.13	145.01	171.94	177.55	151.4	168.3	220.23	209.26	145.31	146.16
Other Current Assets	77M	2M	10M	1.22B	1.54B	39M	1.11B	858M	850.45M	887M
Total Non-Current Assets	32.75B	28.28B	26.89B	25.86B	23.59B	21.44B	21.75B	20.75B	20.17B	18.52B
Property, Plant & Equipment	1.4B	1.35B	1.47B	1.57B	1.6B	1.6B	1.71B	1.78B	2.07B	2.1B
Fixed Asset Turnover	6.22x	6.19x	5.87x	5.12x	5.28x	5.08x	5.13x	5.41x	5.05x	5.16x
Goodwill	15.59B	13.14B	13.13B	13.04B	12.46B	11.55B	11.18B	11.09B	11.25B	9.81B
Intangible Assets	15.21B	12B	10.2B	8.45B	6.95B	5.8B	6.46B	5.55B	4.63B	4.4B
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	111M	109M	411M	664M	340M	326M	307M	363M	377.31M	1.52B
Total Assets	37.5B▲ 0%	27.45B▼ 26.8%	33.86B▲ 23.4%	31.2B▼ 7.9%	29.2B▼ 6.4%	25.69B▼ 12.0%	27.35B▲ 6.5%	26.52B▼ 3.0%	26.32B▼ 0.8%	24.5B▲ 0%
Asset Turnover	0.23x	0.31x	0.25x	0.26x	0.29x	0.32x	0.32x	0.36x	0.40x	0.40x
Asset Growth %	-13.86%	-26.8%	23.38%	-7.87%	-6.4%	-12.04%	6.48%	-3.02%	-0.77%	-4.17%
Total Current Liabilities	4.27B	3.84B	6.25B	4.91B	5.2B	3.94B	4.3B	6.75B	4.17B	4.53B
Accounts Payable	365M	411M	503M	337M	407M	521M	719M	656M	598.91M	593M
Days Payables Outstanding	52.29	63.81	78.13	54.69	62.05	80.44	102.55	86.07	53.52	54.92
Short-Term Debt	209M	228M	1.23B	0	0	432M	450M	2.67B	296.46M	889M
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	1.21B	946M	2.42B	2.75B	2.98B	1.34B	1.4B	1.33B	2.85B	1.15B
Current Ratio	1.11x	0.19x	1.12x	1.09x	1.08x	1.08x	1.30x	0.86x	1.47x	1.47x
Quick Ratio	0.87x	-0.06x	0.94x	0.86x	0.89x	0.80x	0.94x	0.62x	1.08x	1.08x
Cash Conversion Cycle	186.96	162.43	171.85	194.57	166.16	168.28	200.95	204.35	173.79	170.47
Total Non-Current Liabilities	27.29B	25.84B	26.48B	25.68B	24.04B	21.48B	23.13B	20.09B	21.77B	21.05B
Long-Term Debt	25.23B	24.08B	24.66B	23.93B	22.65B	20.33B	21.94B	18.94B	20.72B	19.88B
Capital Lease Obligations	0	0	0	0	0	0	0	165M	189.65M	209.65M
Deferred Tax Liabilities	1.18B	885M	705M	528M	529M	202M	163M	128M	146.73M	614.59M
Other Non-Current Liabilities	870M	879M	1.11B	1.23B	855M	949M	1.03B	857.49M	711.7M	3.89B
Total Liabilities	31.55B	29.68B	32.73B	30.59B	29.24B	25.43B	27.43B	26.84B	25.94B	25.58B
Total Debt	25.44B	24.3B	25.89B	23.93B	22.65B	20.77B	22.39B	21.83B	21.21B	20.8B
Net Debt	24.72B	23.58B	22.65B	23.32B	22.07B	20.2B	21.44B	20.65B	19.88B	19.5B
Debt / Equity	4.28x	8.63x	22.79x	39.55x	-	79.87x	-	-	56.36x	56.36x
Debt / EBITDA	8.60x	55.87x	13.83x	9.57x	11.32x	11.24x	10.05x	7.76x	6.14x	5.75x
Net Debt / EBITDA	8.35x	54.22x	12.10x	9.32x	11.02x	10.93x	9.63x	7.34x	5.76x	5.76x
Interest Coverage	0.30x	0.30x	0.83x	0.86x	1.20x	1.01x	1.22x	1.35x	1.35x	1.43x
Total Equity	5.94B▲ 0%	2.81B▼ 52.6%	1.14B▼ 59.6%	605M▼ 46.7%	-34M▼ 105.6%	260M▲ 864.7%	-82M▼ 131.5%	-322M▼ 292.7%	376.31M▲ 216.9%	-1.08B▲ 0%
Equity Growth %	82.44%	-52.64%	-59.64%	-46.74%	-105.62%	864.71%	-131.54%	-292.68%	216.87%	277.76%
Book Value per Share	16.90	8.05	3.23	1.70	-0.09	0.72	-0.22	-0.88	1.00	-2.90
Total Shareholders' Equity	5.85B	2.73B	1.06B	535M	-106M	-692M	-1.02B	-1.28B	-552.99M	-2.06B
Common Stock	10.09B	10.12B	10.17B	10.23B	10.32B	10.39B	10.42B	10.49B	10.5B	10.54B
Retained Earnings	-2.73B	-5.66B	-7.45B	-8.01B	-8.96B	-9.19B	-9.78B	-9.82B	-9.65B	-11.09B
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-1.9B	-2.14B	-2.09B	-2.13B	-1.92B	-2.06B	-1.88B	-2.18B	-1.76B	-1.81B
Minority Interest	95M	82M	73M	70M	72M	952M	940M	957M	929.31M	977M

BHC Cash Flow Statement

Bausch Health Companies Inc. (BHC) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	2.29B	1.5B	1.5B	1.11B	1.43B	-728M	1.03B	1.6B	1.4B	1.4B
Operating CF Margin %	26.25%	17.91%	17.45%	13.84%	16.91%	-8.96%	11.78%	16.59%	13.4%	-
Operating CF Growth %	9.73%	-34.45%	0%	-25.98%	28.35%	-151.05%	241.76%	54.75%	-12.34%	-31.85%
Net Income	2.4B	-4.14B	-1.78B	-559M	-937M	-212M	-611M	-72M	120M	-1.19B
Depreciation & Amortization	2.86B	2.82B	2.08B	1.82B	1.55B	1.39B	1.26B	1.27B	1.21B	1.2B
Stock-Based Compensation	87M	87M	102M	105M	128M	126M	132M	150M	216M	141M
Deferred Taxes	-4.39B	-144M	-230M	-475M	-225M	-176M	51M	66M	80M	121.77M
Other Non-Cash Items	483M	2.87B	1.66B	581M	1.04B	-1.46B	778M	179M	-1.17M	1.55B
Working Capital Changes	844M	18M	-318M	-366M	-128M	-396M	-582M	7M	-222.83M	-363.34M
Change in Receivables	417M	216M	39M	170M	-229M	-57M	-195M	-216M	-136.35M	-94.72M
Change in Inventory	7M	-5M	-209M	-77M	-16M	-198M	-322M	-267M	-12.21M	3.92M
Change in Payables	387M	-568M	-149M	-471M	121M	-75M	158M	357M	-77.33M	-439.12M
Cash from Investing	2.89B	-196M	-419M	-261M	409M	-303M	-2.15B	-454M	-595M	-608.71M
Capital Expenditures	-336M	-235M	-278M	-302M	-269M	-218M	-215M	-337M	-397M	-392.38M
CapEx % of Revenue	3.85%	2.8%	3.23%	3.76%	3.19%	2.68%	2.46%	3.5%	3.8%	-
Acquisitions	-165M	5M	-180M	0	0	-45M	-1.89B	0	0	-195.27M
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	3.39B	34M	45M	37M	682M	-45M	-39M	-119M	-195M	-18.01M
Cash from Financing	-4.96B	-1.35B	1.44B	-2.29B	-1.51B	-474M	1.48B	-868M	-742M	-692.65M
Debt Issued (Net)	-4.78B	-1.16B	1.55B	-2.19B	-1.34B	-1.01B	1.58B	-799M	-648.15M	-577.53M
Equity Issued (Net)	0	-10M	-40M	0	0	675M	0	-26M	0	-3M
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-4M	-10M	-40M	0	0	0	0	-26M	0	-3M
Other Financing	-184M	-186M	-71M	-107M	-173M	-139M	-106M	-43M	-93.85M	-112.12M
Net Change in Cash	255M▲ 0%	-74M▼ 129.0%	2.52B▲ 3506.8%	-1.43B▼ 156.6%	303M▲ 121.2%	-1.53B▼ 604.3%	371M▲ 124.3%	239M▼ 35.6%	124M▼ 48.1%	153.89M▲ 0%
Free Cash Flow	1.95B▲ 0%	1.27B▼ 35.2%	1.22B▼ 3.4%	802M▼ 34.4%	1.14B▲ 42.5%	-996M▼ 187.1%	760M▲ 176.3%	1.26B▲ 65.8%	1B▼ 20.4%	989.53M▲ 0%
FCF Margin %	22.4%	15.11%	14.22%	9.99%	13.55%	-12.26%	8.68%	13.09%	9.6%	9.38%
FCF Growth %	8.8%	-35.21%	-3.4%	-34.42%	42.52%	-187.14%	176.31%	65.79%	-20.4%	-18.5%
FCF per Share	5.55	3.62	3.47	2.26	3.18	-2.75	2.08	3.42	2.67	2.67
FCF Conversion (FCF/Net Income)	0.95x	-0.36x	-0.84x	-1.99x	-1.50x	3.24x	-1.74x	-34.72x	8.76x	-0.83x
Interest Paid	1.71B	0	0	0	0	1.54B	1.53B	1.67B	0	0
Taxes Paid	179M	0	0	0	0	266M	237M	61M	0	0

BHC Key Ratios

Bausch Health Companies Inc. (BHC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	52.25%	-94.71%	-90.26%	-64.22%	-332.05%	-199.12%	-665.17%	-	588.24%	2343.44%
Return on Invested Capital (ROIC)	0.24%	-6.27%	-0.61%	2.13%	1.47%	1.6%	3.45%	5.56%	8.22%	8.22%
Gross Margin	70.79%	71.95%	72.68%	71.98%	71.61%	70.9%	70.78%	71.1%	60.9%	61.67%
Net Margin	27.56%	-49.5%	-20.73%	-6.96%	-11.24%	-2.77%	-6.76%	-0.48%	1.53%	-11.27%
Debt / Equity	4.28x	8.63x	22.79x	39.55x	-	79.87x	-	-	56.36x	56.36x
Interest Coverage	0.30x	0.30x	0.83x	0.86x	1.20x	1.01x	1.22x	1.35x	1.35x	1.43x
FCF Conversion	0.95x	-0.36x	-0.84x	-1.99x	-1.50x	3.24x	-1.74x	-34.72x	8.76x	-0.83x
Revenue Growth	-9.82%	-3.94%	2.64%	-6.67%	5.07%	-3.68%	7.79%	9.91%	8.53%	8.52%

BHC SEC Filings & Documents

Bausch Health Companies Inc. (BHC) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 29, 2026·SEC

Material company update

Mar 2, 2026·SEC

Material company update

Feb 18, 2026·SEC

10-K Annual Reports

FY 2026

Feb 19, 2026·SEC

FY 2025

Feb 20, 2025·SEC

FY 2024

Feb 22, 2024·SEC

10-Q Quarterly Reports

FY 2025

Oct 30, 2025·SEC

FY 2025

Jul 31, 2025·SEC

FY 2025

May 1, 2025·SEC

BHC Frequently Asked Questions

Bausch Health Companies Inc. (BHC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Bausch Health Companies Inc. (BHC) reported $10.55B in revenue for fiscal year 2025. This represents a 15792% increase from $66.4M in 1996.

Bausch Health Companies Inc. (BHC) grew revenue by 8.5% over the past year. This is steady growth.

Bausch Health Companies Inc. (BHC) reported a net loss of $1.19B for fiscal year 2025.

Dividend & Returns

Bausch Health Companies Inc. (BHC) has a return on equity (ROE) of 588.2%. This is excellent, indicating efficient use of shareholder capital.

Bausch Health Companies Inc. (BHC) generated $989.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More BHC

Bausch Health Companies Inc. (BHC) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Bausch Health Companies Inc.(BHC)Earnings, Financials & Key Ratios

BHC Key Insights

✓Strengths

✗Weaknesses

BHC Price & Volume

BHC Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

BHC Recent Earnings

BHC Peer Comparison

Compare BHC vs Peers

vs PBH

vs NVS

Compare Top 5

BHC Income Statement

BHC Balance Sheet

BHC Cash Flow Statement

BHC Key Ratios

BHC SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

BHC Frequently Asked Questions

Explore More BHC

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation